This content is restricted.
Brief
"On November 19, 2024, the Therapeutic Goods Administration (TGA) issued an update regarding promethazine hydrochloride (Phenergan) not to be used in children under 6. This advice follows a TGA investigation and advice from the Advisory Committee on Medicines (ACM) in 2022, with warnings published in a previous Medicines Safety Update. " The updated advice includes a warning of psychiatric and central nervous system side effects in children under 6, including hyperactivity, aggression, and hallucination, as well as difficulties in learning and understanding, such as reversible cognitive deficit and intellectual disability, when high doses are given."
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
